James R. McNab - 28 Jan 2022 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
Director
Signature
/S/ James R. McNab
Issuer symbol
TTNP
Transactions as of
28 Jan 2022
Net transactions value
$0
Form type
4
Filing time
28 Jan 2022, 14:14:28 UTC
Previous filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTNP Common Stock Other +51,021 51,021 28 Jan 2022 By JT Pharma F1
holding TTNP Common Stock 1,669 28 Jan 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents $50,000 of shares issued to JT Pharmaceuticals, Inc. ("JT") as a milestone payment under the October 2020 asset purchase agreement. Mr. McNab is a principal of JT and has voting and dispositive control of such shares.